Page last updated: 2024-08-17

carbostyril and Peripheral Nerve Diseases

carbostyril has been researched along with Peripheral Nerve Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrosius, B; Gold, R; Hayardeny, L; Hayden, M; Pitarokoili, K; Schrewe, L1
Kusnir, D; LoPiccolo, M; Sandoz, A; Tausk, FA1
Angevin, E; Escudier, B; Lambotte, O; Loriot, Y; Massard, C; Soria, JC1
Hori, S1
Belly, RT; Bol, CJ; Bowden, C; Chiao, J; Chow, C; Cowan, KH; End, DW; Gress, RE; Hakim, FT; Horak, ID; Kohler, DR; Kopp, WC; Kremer, AB; Larkin, G; Noone, M; Nussenblatt, RB; Piotrovsky, VK; Todd, A; Woestenborghs, R; Zujewski, J1

Reviews

2 review(s) available for carbostyril and Peripheral Nerve Diseases

ArticleYear
A clinical paradigm of delusions of parasitosis.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:4

    Topics: Aged; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Diagnosis, Differential; Female; Humans; Metabolic Syndrome; Middle Aged; Olanzapine; Pain; Patient Compliance; Peripheral Nervous System Diseases; Piperazines; Quinolones; Schizophrenia, Paranoid; Skin Diseases, Parasitic; Sleep Wake Disorders

2008
[Adverse effects and safety of antimicrobial agents-neurotoxicities].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Drug Interactions; Humans; Isoniazid; Neuromuscular Junction Diseases; Peripheral Nervous System Diseases; Quinolones; Tetracyclines

2007

Trials

1 trial(s) available for carbostyril and Peripheral Nerve Diseases

ArticleYear
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4

    Topics: Administration, Oral; Adult; Aged; Alkyl and Aryl Transferases; Anemia; Biological Availability; Bone Marrow; Capsules; Drug Administration Schedule; Enzyme Inhibitors; Farnesyltranstransferase; Fatigue; Female; Half-Life; Headache; Humans; Hypotension; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Peripheral Nervous System Diseases; Quinolones; Solutions; Vomiting

2000

Other Studies

2 other study(ies) available for carbostyril and Peripheral Nerve Diseases

ArticleYear
Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis.
    Journal of neuroimmunology, 2014, Sep-15, Volume: 274, Issue:1-2

    Topics: Animals; Autoimmunity; Disease Models, Animal; Female; Immunization; Immunologic Factors; Macrophages; Motor Neurons; Neural Conduction; Neuritis, Autoimmune, Experimental; Peripheral Nervous System Diseases; Quinolones; Rats; Rats, Inbred Lew; Sciatic Nerve; T-Lymphocytes

2014
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:7

    Topics: Benzimidazoles; Carcinoma, Renal Cell; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; ErbB Receptors; Humans; Kidney Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2010